Ignyte Acquisition Corp. (NASDAQ:IGNY) announced this morning that its shareholders approved its combination with biopharmaceutical firm Peak Bio at a special meeting on October 25.
The press release did not divulge redemption figures, but noted that the vote received roughly 75% turnout and 75% approval. The SPAC pre-emptively postponed an earlier completion vote scheduled for October 24, likely to help boost turnout, and these efforts appear to have paid off.
As a result, Ignyte has also canceled an October 31 special meeting to extend its November 2 transaction deadline, which may have been necessary if there were further delays.
Once the deal is completed, Peak Bio is expected to trade on the Nasdaq under the symbol “PKBO”. Ignyte and Peak Bio announced their $205 million combination on April 29. Silicon Valley-based Peak Bio is currently developing treatments for respiratory illnesses and cancer with its most advanced drug candidate in Phase II trials.
ADVISORS
- Chardan is serving as the financial advisors to Ignyte
- Ladenburg Thalmann & Co. Inc. is serving as the financial advisors Peak Bio.
- DLA Piper LLP (US) is serving as legal advisor to Ignyte.
- Bae, Kim & Lee LLC and B C Burr McCabe Law are serving as legal advisors to Peak Bio.
Indigo Acquisition Corp. (NASDAQ:INACU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “INACU”, Tuesday, July 1, 2025. The new SPAC plans to combine with an established, profitable company whose growth potential can benefit from its team’s expertise. Indigo’s management team is...
After a quiet June, July is set to be active throughout the month with nine de-SPACs and sponsors coming unlocked from their trading restrictions. This timing is most fortuitous for insurance investor Abacus Life (NASDAQ:ABL) and East Resources, which took it public in 2023, as it is the best performer of this group of companies...
Pyrophyte II (NYSE:PAII.U) has filed for a $175 million SPAC to dig for a natural resources target while the team’s first deal remains pending. The new SPAC is offering investors 1/2 warrants in each unit and it will have 24 months to complete a business combination without asking shareholders for an extension. It is the...
At the SPAC of Dawn The last day of the quarter is to play host to a pair of shareholder votes and a possible pricing of Indigo‘s (NASDAQ:INACU) $100 million IPO. This week is also to play host to fresh jobs numbers just before the long July 4 weekend. Black Hawk (NASDAQ:BKHA) was also one...
Terms Tracker for the Week Ending June 27, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. June continued its late-month rally with another five SPAC IPOs pricing this week, bringing the monthly total to 10 and the 2025 year-to-date count to...